¿Cuál es la eficacia, efectividad, seguridad del uso off- label de rituximab en esclerosis múltiple remitente- recurrente?
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , |
| Format: | article |
| Language: | Spanish |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/20.500.12008/31061 |
| Tags: |
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!